How This Evidence Evolved
Portal Vein Embolization and ALPPS
Strategies to Augment Future Liver Remnant Volume for Extended Hepatic Resection
Timeline
Early observations and pilot data that first suggested a new direction
Landmark RCTs and pivotal trials that established the evidence base
Follow-up studies, subgroup analyses, and real-world validation
Clavien-Dindo grade 3 or higher morbidity and mortality, first registry report (202 procedures): 27% and 9% (single arm)
Left lateral lobe volume increase at a median 9 days (range 5-28) after step 1: median 74% (range 21%-192%; P < 0.001)
Integration into clinical practice guidelines and recommendations
PVE first-line before major hepatectomy; proposed strategies after insufficient PVE regeneration include sequential HVE, LVD, DVE and ALPPS.
PVE is the first-line approach to induce FLR hypertrophy before major hepatectomy; suggested safe FLR/TLV >20% normal, >30% prior chemotherapy, >40% cirrhotic/cholestatic liver.
Current standard of care and ongoing research directions
Landmark Trials in This Story
Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report
Embolized-lobe atrophy at hepatectomy, 6-41 days after embolization: 12/14; no major embolization side effects; 2 later postoperative deaths
Portal vein embolization before right hepatectomy: prospective clinical trial.
Mean FLR increase 4-8 weeks after PVE: normal liver 44% ± 19% vs chronic liver disease 35% ± 28%
Associated Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Registry: What Have We Learned?
Clavien-Dindo grade 3 or higher morbidity and mortality, first registry report (202 procedures): 27% and 9% (single arm)
Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings.
Left lateral lobe volume increase at a median 9 days (range 5-28) after step 1: median 74% (range 21%-192%; P < 0.001)
Comparison of liver venous deprivation with portal vein embolization alone in patients undergoing major liver resection: a systematic review and meta-analysis.
LVD vs PVE: resection OR 1.89 (95% CI 1.13–3.15); 90-day mortality OR 0.38 (95% CI 0.13–1.09), not significant
Explore the evidence yourself
Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3.7M+ peer-reviewed articles.